CPH
C Partners Holding Portfolio holdings
AUM
$455M
This Quarter Return
+1.5%
1 Year Return
+22.57%
3 Year Return
+65.69%
5 Year Return
+108.46%
10 Year Return
+270.06%
AUM
$313M
AUM Growth
+$313M
(+1.4%)
Cap. Flow
+$1.78M
Cap. Flow
% of AUM
0.57%
Top 10 Holdings %
Top 10 Hldgs %
70.79%
Holding
53
New
4
Increased
6
Reduced
4
Closed
7
Top Buys
| 1 |
SPDR Gold Trust
GLD
|
$28.1M |
| 2 |
AKRX
Akorn, Inc.
AKRX
|
$1.57M |
| 3 |
Cerus
CERS
|
$980K |
| 4 |
Boston Scientific
BSX
|
$888K |
| 5 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
$683K |
Top Sells
| 1 |
Medtronic
MDT
|
$6.96M |
| 2 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$6.11M |
| 3 |
Yum! Brands
YUM
|
$4.22M |
| 4 |
Qualcomm
QCOM
|
$4.05M |
| 5 |
Johnson & Johnson
JNJ
|
$3.93M |
Sector Composition
| 1 | Healthcare | 15.27% |
| 2 | Materials | 12.1% |
| 3 | Consumer Discretionary | 5% |
| 4 | Consumer Staples | 2.88% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Johnson & Johnson
JNJ
$427B
| $3.03M | 0.97% |
30,089
-39,062
| -56% | -$3.93M |
|
27
Abbott
ABT
$231B
| $2.42M | 0.77% |
52,137
| – | – |
|
28
AbbVie
ABBV
$372B
| $1.93M | 0.62% |
33,000
+7,000
| +27% | +$410K |
|
29
Cardinal Health
CAH
$35.5B
| $1.9M | 0.61% |
21,000
| – | – |
|
|
HPTX
30
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $1.88M | 0.6% |
41,000
-18,000
| -31% | -$826K |
|
|
31
Boston Scientific
BSX
$156B
| $1.86M | 0.6% |
105,000
+50,000
| +91% | +$888K |
|
32
Pfizer
PFE
$141B
| $1.74M | 0.56% |
50,000
| – | – |
|
33
Revvity
RVTY
$10.5B
| $1.69M | 0.54% |
33,000
| – | – |
|
34
IQVIA
IQV
$32.4B
| $1.67M | 0.53% |
25,000
| – | – |
|
35
Teva Pharmaceuticals
TEVA
$21.1B
| $1.62M | 0.52% |
26,000
| – | – |
|
|
AKRX
36
DELISTED
Akorn, Inc.
AKRX
| $1.57M | 0.5% |
+33,000
| New | +$1.57M |
|
37
Perrigo
PRGO
$3.27B
| $1.53M | 0.49% |
9,262
+3,100
| +50% | +$513K |
|
38
Biogen
BIIB
$19.4B
| $1.52M | 0.49% |
3,600
-1,500
| -29% | -$633K |
|
|
BDSI
39
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.26M | 0.4% |
120,000
+65,000
| +118% | +$683K |
|
|
40
Cerus
CERS
$251M
| $980K | 0.31% |
+235,000
| New | +$980K |
|
41
Thermo Fisher Scientific
TMO
$186B
| $846K | 0.27% |
6,300
| – | – |
|
42
Stryker
SYK
$150B
| $738K | 0.24% |
8,000
| – | – |
|
|
SYNH
43
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $674K | 0.22% |
+20,600
| New | +$674K |
|
44
Dynavax Technologies
DVAX
$1.19B
| $464K | 0.15% |
20,697
| – | – |
|
|
RDUS
45
DELISTED
Radius Health, Inc.
RDUS
| $395K | 0.13% |
+9,600
| New | +$395K |
|
|
SCPX
46
DELISTED
Scorpius Holdings, Inc.
SCPX
| $318K | 0.1% |
50,000
| – | – |
|
|
47
Medtronic
MDT
$119B
| – | – |
-96,346
| Closed | -$6.96M |
|
|
48
Qualcomm
QCOM
$173B
| – | – |
-54,502
| Closed | -$4.05M |
|
49
Viatris
VTRS
$12.3B
| – | – |
-58,000
| Closed | -$3.27M |
|
|
50
Yum! Brands
YUM
$40.8B
| – | – |
-57,931
| Closed | -$4.22M |
|